---
title: 'Safety and tolerability of radiotherapy in combination with systemic targeted
  therapies for treatment of hepatocellular carcinoma: a narrative review'
date: '2024-05-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38769795/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240521183404&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Existing data suggests that combination RT and targeted
  therapy given the risk of severe adverse events including hepatotoxicity and GI
  toxicity. There is an urgent need for future studies specifically examining the
  impact of combination therapy in HCC patients to guide clinical decision-making
  in the evolving landscape of immune- and targeted ...'
disable_comments: true
---
CONCLUSIONS: Existing data suggests that combination RT and targeted therapy given the risk of severe adverse events including hepatotoxicity and GI toxicity. There is an urgent need for future studies specifically examining the impact of combination therapy in HCC patients to guide clinical decision-making in the evolving landscape of immune- and targeted ...